S
Sionna Therapeutics, Inc. (SION)
NGM – Real Time Price. Currency in USD
40.94
-5.01 (-10.90%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
40.94
-5.01 (-10.90%)
At close: May 12, 2026, 4:00 PM EDT
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector that has completed Phase 1 trial; SION-2851, a TMD1-directed CFTR corrector that has completed Phase 1 trial; SION-451, which is nucleotide-binding domain 1 stabilizer in Phase 1 trial; and SION-719, which is nucleotide-binding domain 1 stabilizer in Phase 2a proof-of-concept trial. The company was formerly known as Sling Therapeutics, Inc. and changed its name to Sionna Therapeutics, Inc. in July 2021. Sionna Therapeutics, Inc. was incorporated in 2019 and is headquartered in Waltham, Massachusetts.
| Name | Position |
|---|---|
| Dr. Charlotte McKee M.D. | Chief Medical Officer |
| Dr. Greg Hurlbut Ph.D. | Co-Founder & Senior VP of Discovery Research |
| Dr. Mark Munson Ph.D. | Co-founder & Senior VP of Medicinal Chemistry |
| Mr. Andy Chu | Vice President of Information & Technology |
| Mr. Michael Cloonan M.B.A. | President, CEO & Director |
| Ms. Caroline Stark Beer M.B.A. | Chief Business Officer |
| Ms. Elena H. Ridloff C.F.A. | Chief Financial Officer |
| Ms. Jennifer Fitzpatrick J.D. | Chief Legal Officer |
| Ms. Meghan Bagshaw | Vice President of Programs, Portfolio & Operations |
| Ms. Vanya Sagar | Chief People Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-12 | 10-Q | sionna-20260331.htm |
| 2026-04-27 | DEFA14A | a2026sionnatherapeuticsinc.htm |
| 2026-04-27 | ARS | ars.htm |
| 2026-03-02 | 8-K | sion-20260302.htm |
| 2026-03-02 | 10-K | sionna-20251231.htm |
| 2025-11-05 | 10-Q | sionna-20250930.htm |
| 2025-08-11 | 8-K | sion-20250811.htm |
| 2025-08-11 | 10-Q | sionna-20250630.htm |
| 2025-06-13 | 8-K | sion-20250612.htm |
| 2025-06-04 | 8-K | d944102d8k.htm |